Eosinophil-Derived Neurotoxin in Childhood Asthma: Correlation With Disease Severity

References

• Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, Eosinophilic inflammation in asthma. N Engl J Med 1990; 323:1033–1039.
   PubMed Web of Science ®Google Scholar
• Ohashi Y, Motojima S, Fukuda T, Makino S. Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. Am Rev Respir Dis 1992; 145:1469–1476.
   PubMed Web of Science ®Google Scholar
• Wardlaw AJ, Brightling C, Green R, Woltmann G, Pavord I. Eosinophils in asthma and other allergic diseases. Br Med Bull 2000; 56:985–1003.
   PubMed Web of Science ®Google Scholar
• Leckie M, Brinke A, Khan J, Diamant Z, O’Connor BJ, Walls CM, Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000; 356:2144–2148.
   PubMed Web of Science ®Google Scholar
• Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 2003; 167:199–204.
   PubMed Web of Science ®Google Scholar
• Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009; 360:973–984.
   PubMed Web of Science ®Google Scholar
• Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE, O’Byrne PM. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009; 360:985–993.
   PubMed Web of Science ®Google Scholar
• Gleich GJ, Adolphson CR. The eosinophil and bronchial asthma: evidence for a critical role of eosinophils in pathophysiology. In: Sanderson CJ, ed. Interleukin-5: From Molecule to Drug Target for Asthma. Lung Biology in Health and Disease. New York: Marcel Dekker, Inc., 1999:1–37.
   Google Scholar
• Venge P, Bystrom J, Carlson M, Hakansson L, Karawacjzyk M, Peterson C, Seveus L, Trulson A. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy 1999; 29:1172–1186.
   PubMed Web of Science ®Google Scholar
• Bergstrand H, Lundquist B, Petersson B, Peterson CG, Venge P. Eosinophil derived cationic protein and human leukocyte histamine release. In: Venge P, Lindblom A, eds. Inflammation: Basic Mechanisms Tissue Injuring Principles and Clinical Models. Stockholm: Almqvist & Wiksell International, 1985:361–365.
   Google Scholar
• Chihara J, Urayama O, Tsuda A, Kakazu T, Higashimoto I, Yamada H. Eosinophil cationic protein induces insulin-like growth factor I receptor expression on bronchial epithelial cells. Int Arch Allergy Immunol 1996; 111:43–45.
   PubMedGoogle Scholar
• Moqbel R, Lace P, Adamko DJ, Odemuyiwa SO. Biology of eosinophils. In: Adkinson NF Jr, Bochner BS, Busse WW, Holgate ST, Lemanske RF Jr, Simons FER, eds. Allergy: Principles & Practice. St. Louis: Mosby, 2008:295–310.
   Google Scholar
• Kim KW, Lee KE, Kim ES, Song TW, Sohn MH, Kim KE. Serum eosinophil-derived neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma. Lung 2007; 185:97–103.
   PubMed Web of Science ®Google Scholar
• Koller DY, Halmerbauer G, Frischer T, Roithner B. Assessment of eosinophil granule proteins in various body fluids: is there a relation to clinical variables in childhood asthma? Clin Exp Allergy 1999; 29:786–793.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma (GINA). Global Strategy for the Diagnosis and Management of Asthma in Children 5 Years and Younger. 2009. Available at: http://www.ginasthma.org.
   Google Scholar
• Morioka J, Kurosawa M, Inamura H, Nakagami R, Mizushima Y, Chihara J, Yokoseki T, Kitamura S, Omura Y, Shibata M. Development of a novel enzyme-linked immunosorbent assay for blood and urinary eosinophil-derived neurotoxin: a preliminary study in patients with bronchial asthma. Int Arch Allergy Immunol 2000; 122:49–57.
   PubMedGoogle Scholar
• Parkin PC, Macarthur C, Saunders MR, Diamond SA, Winders PM. Development of a clinical asthma score for use in hospitalized children between 1 and 5 years of age. J Clin Epidemiol 1996; 49:821–825.
   PubMed Web of Science ®Google Scholar
• Venge P. Monitoring the allergic inflammation. Allergy 2004; 59:26–32.
   PubMed Web of Science ®Google Scholar
• Taniuchi S, Chihara J, Kojima T, Yamamoto A, Sasai M, Kobayashi Y. Serum eosinophil derived neurotoxin may reflect more strongly disease severity in childhood atopic dermatitis than eosinophil cationic protein. J Dermatol Sci 2001; 26:79–82.
   PubMed Web of Science ®Google Scholar
• Lugosi E, Halmerbauer G, Frischer T, Koller DY. Urinary eosinophil protein X in relation to disease activity in childhood asthma. Allergy 1997; 52:584–588.
   PubMedGoogle Scholar
• Kristjannson S, Strannegard IL, Strannegard O, Perterson C, Enander I, Wennergren G. Urinary eosinophil protein X in children with atopic asthma: a useful marker of anti-inflammatory treatment. J Allergy Clin Immunol 1996; 97:1179–1187.
   PubMedGoogle Scholar
• Goto T, Morioka J, Inamura H, Yano M, Kodaira K, Igarashi Y, Abe S, Kurosawa M. Urinary eosinophil-derived neurotoxin concentrations in patients with atopic dermatitis: a useful clinical marker for disease activity. Allergol Int 2007; 56:433–438.
   PubMedGoogle Scholar
• Tauber E, Halmerbauer G, Frischer T, Gartner C, Horak F Jr, Veiter A, Koller DY, Studnicka M. Urinary eosinophil protein X in children: the relationship to asthma and atopy and normal values. Allergy 2000; 55:647–652.
   PubMedGoogle Scholar
• Wojnarowski C, Roithner B, Koller DY, Halmerbauer G, Gartner C, Tauber E, Frischer T. Lack of relationship between eosinophil cationic protein and eosinophil protein X in nasal lavage and urine and the severity of childhood asthma in a 6-month follow-up study. Clin Exp Allergy 1999; 29:926–932.
   PubMedGoogle Scholar
• Wolthers OD. Eosinophil granule proteins in the assessment of airway inflammation in pediatric bronchial asthma. Pediatr Allergy Immunol 2003; 14:248–254.
   PubMedGoogle Scholar
• Remes S, Korppi M, Remes K, Savolainen K, Mononen I, Pekkanen J. Serum eosinophil cationic protein (ECP) and eosinophil protein X (EPX) in childhood asthma: the influence of atopy. Pediatr Pulmonol 1998; 25:167–174.
   PubMedGoogle Scholar
• Gleich GJ, Adolphson CR. The eosinophilic leukocyte: structure and function. Adv Immunol 1986; 39:177–253.
   PubMed Web of Science ®Google Scholar
• Sedgwick JB, Vrtis RF, Jansen KJ, Kita H, Bartemes K, Busse WW. Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin. J Allergy Clin Immunol 2004; 114:568–574.
   PubMedGoogle Scholar
• Pronk-Admiraal CJ, Bartels PC. Scand J Clin Lab Invest 2001; 61:453–457.
   PubMed Web of Science ®Google Scholar
• Abu-Ghazaleh RI, Dunnette SL, Loegering DA, Checkel JL, Kita H, Thomas LL, Gleich GJ. Eosinophil granule proteins in peripheral blood granulocytes. J Leukoc Biol 1992; 52:611–618.
   PubMed Web of Science ®Google Scholar
• Pizzichini E, Pizzichini MM, Efthimiadis A, Dolovich J, Hargreave FE. Measuring airway inflammation in asthma: eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood. J Allergy Clin Immunol 1997; 99:539–544.
   PubMed Web of Science ®Google Scholar
• Scher H, Berman D, Weinberg EG, Schinkel M, Peper B, Chalton DO, Potter PC. Granulocyte proteins in serum in childhood asthma: relation to spirometry and therapy. Clin Exp Allergy 1996; 26:1131–1141.
   PubMed Web of Science ®Google Scholar
• Meijer RJ, Kerstjens HA, Arends LR, Kauffman HF, Koeter GH, Postma DS. Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma. Thorax 1999; 54:894–899.
   PubMed Web of Science ®Google Scholar
• Winqvist I, Olofsson T, Olsson I. Mechanisms for eosinophil degranulation: release of the eosinophil cationic protein. Immunology 1984; 51:1–8.
   PubMedGoogle Scholar
• Kita H, Abu-Ghazaleh R, Sanderson CJ, Gleich GJ. Effect of steroids on immunoglobulin-induced eosinophil degranulation. J Allergy Clin Immunol 1991; 87:70–77.
   PubMedGoogle Scholar
• Gleeson JG, Loftus BG, Price JF. Placebo controlled trial of systemic corticosteroids in acute childhood asthma. Acta Paediatr Scand 1990; 79:1052–1058.
   PubMed Web of Science ®Google Scholar